Exposures Through Breast Milk: An Analysis of Exposure and Information Calls to U.S. Poison Centers, 2001-2017

Gillian A. Beauchamp, Robert Hendrickson, B (Zane) Horowitz, Daniel A. Spyker

Research output: Contribution to journalReview article

Abstract

Introduction: We described calls to U.S. poison centers (PCs) related to potential exposure to substances through breast milk. Materials and Methods: We analyzed National Poison Data System calls between 2001 and 2017 with "Exposure through breast milk" or "Drug use during breastfeeding" as the coded scenario. Data handling and descriptive statistics were carried out using SAS JMP 12.01. Results: U.S. PCs received 76,416 information calls and 2,319 exposure calls related to breast milk. Exposure calls were from a residence in 76% (n = 1,758), from health care facilities (HCFs) in 15.5% (n = 360), and from a workplace in 0.6% (n = 15). A total of 466 exposures (20.1%) were subsequently managed at a HCF: 269 were evaluated and released (58%), 38 were admitted to intensive care unit (8.2%), and 53 were admitted to hospital floor (11%). Medical outcomes included 1 death (0.04%), 8 major effect (0.3%), 43 moderate effect (1.9%), 170 minor effect (7.3%), and 390 no effect (16.8%). Exposure calls that reported major effects involved opioids, benzodiazepines, ethanol, cyclobenzaprine, insulin, and amphetamines. Exposure calls most commonly involved antibiotics, antifungals, benzodiazepines, opioids, and selective serotonin reuptake inhibitors (SSRIs). A total of 1,192 exposures (51.4%) had reported signs/symptoms including drowsiness, agitation, rash, and vomiting/diarrhea. Information calls most commonly involved systemic antibiotics, SSRIs, antihistamines, corticosteroids, and benzodiazepines. Conclusions: Substances common to both exposure and information calls included antibiotics, benzodiazepines, and SSRIs. Most cases of severe toxicity included potential exposures through breast milk to benzodiazepines and opioids. These data may help inform educational outreach, risk assessment, and bedside care for breastfeeding mothers.

Original languageEnglish (US)
Pages (from-to)508-512
Number of pages5
JournalBreastfeeding Medicine
Volume14
Issue number7
DOIs
StatePublished - Sep 1 2019

Fingerprint

Poisons
Human Milk
Benzodiazepines
Serotonin Uptake Inhibitors
Opioid Analgesics
Health Facilities
Breast Feeding
Anti-Bacterial Agents
Delivery of Health Care
Amphetamines
Antifungal Agents
Sleep Stages
Histamine Antagonists
Exanthema
Information Systems
Workplace
Signs and Symptoms
Vomiting
Intensive Care Units
Diarrhea

Keywords

  • breastfeeding
  • exposures
  • information calls
  • poison centers
  • poisoning

ASJC Scopus subject areas

  • Pediatrics
  • Health Policy
  • Obstetrics and Gynecology
  • Maternity and Midwifery

Cite this

Exposures Through Breast Milk : An Analysis of Exposure and Information Calls to U.S. Poison Centers, 2001-2017. / Beauchamp, Gillian A.; Hendrickson, Robert; Horowitz, B (Zane); Spyker, Daniel A.

In: Breastfeeding Medicine, Vol. 14, No. 7, 01.09.2019, p. 508-512.

Research output: Contribution to journalReview article

@article{9079339f72fb4d42bb7ddabd3dc7d50e,
title = "Exposures Through Breast Milk: An Analysis of Exposure and Information Calls to U.S. Poison Centers, 2001-2017",
abstract = "Introduction: We described calls to U.S. poison centers (PCs) related to potential exposure to substances through breast milk. Materials and Methods: We analyzed National Poison Data System calls between 2001 and 2017 with {"}Exposure through breast milk{"} or {"}Drug use during breastfeeding{"} as the coded scenario. Data handling and descriptive statistics were carried out using SAS JMP 12.01. Results: U.S. PCs received 76,416 information calls and 2,319 exposure calls related to breast milk. Exposure calls were from a residence in 76{\%} (n = 1,758), from health care facilities (HCFs) in 15.5{\%} (n = 360), and from a workplace in 0.6{\%} (n = 15). A total of 466 exposures (20.1{\%}) were subsequently managed at a HCF: 269 were evaluated and released (58{\%}), 38 were admitted to intensive care unit (8.2{\%}), and 53 were admitted to hospital floor (11{\%}). Medical outcomes included 1 death (0.04{\%}), 8 major effect (0.3{\%}), 43 moderate effect (1.9{\%}), 170 minor effect (7.3{\%}), and 390 no effect (16.8{\%}). Exposure calls that reported major effects involved opioids, benzodiazepines, ethanol, cyclobenzaprine, insulin, and amphetamines. Exposure calls most commonly involved antibiotics, antifungals, benzodiazepines, opioids, and selective serotonin reuptake inhibitors (SSRIs). A total of 1,192 exposures (51.4{\%}) had reported signs/symptoms including drowsiness, agitation, rash, and vomiting/diarrhea. Information calls most commonly involved systemic antibiotics, SSRIs, antihistamines, corticosteroids, and benzodiazepines. Conclusions: Substances common to both exposure and information calls included antibiotics, benzodiazepines, and SSRIs. Most cases of severe toxicity included potential exposures through breast milk to benzodiazepines and opioids. These data may help inform educational outreach, risk assessment, and bedside care for breastfeeding mothers.",
keywords = "breastfeeding, exposures, information calls, poison centers, poisoning",
author = "Beauchamp, {Gillian A.} and Robert Hendrickson and Horowitz, {B (Zane)} and Spyker, {Daniel A.}",
year = "2019",
month = "9",
day = "1",
doi = "10.1089/bfm.2019.0075",
language = "English (US)",
volume = "14",
pages = "508--512",
journal = "Breastfeeding Medicine",
issn = "1556-8253",
publisher = "Mary Ann Liebert Inc.",
number = "7",

}

TY - JOUR

T1 - Exposures Through Breast Milk

T2 - An Analysis of Exposure and Information Calls to U.S. Poison Centers, 2001-2017

AU - Beauchamp, Gillian A.

AU - Hendrickson, Robert

AU - Horowitz, B (Zane)

AU - Spyker, Daniel A.

PY - 2019/9/1

Y1 - 2019/9/1

N2 - Introduction: We described calls to U.S. poison centers (PCs) related to potential exposure to substances through breast milk. Materials and Methods: We analyzed National Poison Data System calls between 2001 and 2017 with "Exposure through breast milk" or "Drug use during breastfeeding" as the coded scenario. Data handling and descriptive statistics were carried out using SAS JMP 12.01. Results: U.S. PCs received 76,416 information calls and 2,319 exposure calls related to breast milk. Exposure calls were from a residence in 76% (n = 1,758), from health care facilities (HCFs) in 15.5% (n = 360), and from a workplace in 0.6% (n = 15). A total of 466 exposures (20.1%) were subsequently managed at a HCF: 269 were evaluated and released (58%), 38 were admitted to intensive care unit (8.2%), and 53 were admitted to hospital floor (11%). Medical outcomes included 1 death (0.04%), 8 major effect (0.3%), 43 moderate effect (1.9%), 170 minor effect (7.3%), and 390 no effect (16.8%). Exposure calls that reported major effects involved opioids, benzodiazepines, ethanol, cyclobenzaprine, insulin, and amphetamines. Exposure calls most commonly involved antibiotics, antifungals, benzodiazepines, opioids, and selective serotonin reuptake inhibitors (SSRIs). A total of 1,192 exposures (51.4%) had reported signs/symptoms including drowsiness, agitation, rash, and vomiting/diarrhea. Information calls most commonly involved systemic antibiotics, SSRIs, antihistamines, corticosteroids, and benzodiazepines. Conclusions: Substances common to both exposure and information calls included antibiotics, benzodiazepines, and SSRIs. Most cases of severe toxicity included potential exposures through breast milk to benzodiazepines and opioids. These data may help inform educational outreach, risk assessment, and bedside care for breastfeeding mothers.

AB - Introduction: We described calls to U.S. poison centers (PCs) related to potential exposure to substances through breast milk. Materials and Methods: We analyzed National Poison Data System calls between 2001 and 2017 with "Exposure through breast milk" or "Drug use during breastfeeding" as the coded scenario. Data handling and descriptive statistics were carried out using SAS JMP 12.01. Results: U.S. PCs received 76,416 information calls and 2,319 exposure calls related to breast milk. Exposure calls were from a residence in 76% (n = 1,758), from health care facilities (HCFs) in 15.5% (n = 360), and from a workplace in 0.6% (n = 15). A total of 466 exposures (20.1%) were subsequently managed at a HCF: 269 were evaluated and released (58%), 38 were admitted to intensive care unit (8.2%), and 53 were admitted to hospital floor (11%). Medical outcomes included 1 death (0.04%), 8 major effect (0.3%), 43 moderate effect (1.9%), 170 minor effect (7.3%), and 390 no effect (16.8%). Exposure calls that reported major effects involved opioids, benzodiazepines, ethanol, cyclobenzaprine, insulin, and amphetamines. Exposure calls most commonly involved antibiotics, antifungals, benzodiazepines, opioids, and selective serotonin reuptake inhibitors (SSRIs). A total of 1,192 exposures (51.4%) had reported signs/symptoms including drowsiness, agitation, rash, and vomiting/diarrhea. Information calls most commonly involved systemic antibiotics, SSRIs, antihistamines, corticosteroids, and benzodiazepines. Conclusions: Substances common to both exposure and information calls included antibiotics, benzodiazepines, and SSRIs. Most cases of severe toxicity included potential exposures through breast milk to benzodiazepines and opioids. These data may help inform educational outreach, risk assessment, and bedside care for breastfeeding mothers.

KW - breastfeeding

KW - exposures

KW - information calls

KW - poison centers

KW - poisoning

UR - http://www.scopus.com/inward/record.url?scp=85072132931&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85072132931&partnerID=8YFLogxK

U2 - 10.1089/bfm.2019.0075

DO - 10.1089/bfm.2019.0075

M3 - Review article

C2 - 31211594

AN - SCOPUS:85072132931

VL - 14

SP - 508

EP - 512

JO - Breastfeeding Medicine

JF - Breastfeeding Medicine

SN - 1556-8253

IS - 7

ER -